Lexaria Bioscience Statistics
Total Valuation
LEXX has a market cap or net worth of $4.71 million. The enterprise value is $1.18 million.
| Market Cap | 4.71M |
| Enterprise Value | 1.18M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026, before market open.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LEXX has 1.65 million shares outstanding. The number of shares has increased by 32.40% in one year.
| Current Share Class | 1.65M |
| Shares Outstanding | 1.65M |
| Shares Change (YoY) | +32.40% |
| Shares Change (QoQ) | +1.48% |
| Owned by Insiders (%) | 1.67% |
| Owned by Institutions (%) | 6.49% |
| Float | 1.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.70 |
| Forward PS | n/a |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.60, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.60 |
| Quick Ratio | 9.56 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -162.77% and return on invested capital (ROIC) is -96.43%.
| Return on Equity (ROE) | -162.77% |
| Return on Assets (ROA) | -81.30% |
| Return on Invested Capital (ROIC) | -96.43% |
| Return on Capital Employed (ROCE) | -170.40% |
| Weighted Average Cost of Capital (WACC) | 7.42% |
| Revenue Per Employee | $27,714 |
| Profits Per Employee | -$1.10M |
| Employee Count | 7 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LEXX has paid $4,403 in taxes.
| Income Tax | 4,403 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.88% in the last 52 weeks. The beta is 0.60, so LEXX's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -78.88% |
| 50-Day Moving Average | 6.01 |
| 200-Day Moving Average | 9.16 |
| Relative Strength Index (RSI) | 39.18 |
| Average Volume (20 Days) | 63,681 |
Short Selling Information
The latest short interest is 274,542, so 16.61% of the outstanding shares have been sold short.
| Short Interest | 274,542 |
| Short Previous Month | 179,002 |
| Short % of Shares Out | 16.61% |
| Short % of Float | 17.13% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, LEXX had revenue of $194,000 and -$7.73 million in losses. Loss per share was -$5.14.
| Revenue | 194,000 |
| Gross Profit | 194,000 |
| Operating Income | -7.49M |
| Pretax Income | -7.74M |
| Net Income | -7.73M |
| EBITDA | -7.42M |
| EBIT | -7.49M |
| Loss Per Share | -$5.14 |
Balance Sheet
The company has $3.62 million in cash and $86,714 in debt, with a net cash position of $3.53 million or $2.14 per share.
| Cash & Cash Equivalents | 3.62M |
| Total Debt | 86,714 |
| Net Cash | 3.53M |
| Net Cash Per Share | $2.14 |
| Equity (Book Value) | 4.34M |
| Book Value Per Share | 2.87 |
| Working Capital | 3.68M |
Cash Flow
In the last 12 months, operating cash flow was -$7.43 million and capital expenditures -$40,817, giving a free cash flow of -$7.47 million.
| Operating Cash Flow | -7.43M |
| Capital Expenditures | -40,817 |
| Depreciation & Amortization | 76,573 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.47M |
| FCF Per Share | -$4.52 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -3,862.94% |
| Pretax Margin | -3,987.65% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LEXX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -32.40% |
| Shareholder Yield | -32.40% |
| Earnings Yield | -180.45% |
| FCF Yield | -155.80% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 30.95% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 3, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 3, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
LEXX has an Altman Z-Score of 2.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 3 |